Alternative Balance between Transcriptional and Epigenetic Regulation during Developmental Proliferation of Human Cranial Neural Crest Cells.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
30 Sep 2024
Historique:
received: 30 08 2024
revised: 27 09 2024
accepted: 28 09 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: epublish

Résumé

Cranial neural crest cells are implicated in multiple transcriptional events at the different stages of differentiation during development. The alteration of some transcription factors expressed during neural crest development, like PAX7, could be implicated in the etiology of face malformation in murine models. Epigenetic regulation has been shown to be an important mechanistic actor in the control of timing and the level of gene expression at different stages of neural crest development. During this work, we investigated the interconnection between epigenetics and transcription factors across a diversity of human development cranial neural crest cells. Across a diversity of neural cells from human developing cranial tissues, in accordance with their proliferation stage, an alternative balance of regulation between transcription factors and epigenetic factors was identified.

Identifiants

pubmed: 39404397
pii: cells13191634
doi: 10.3390/cells13191634
pii:
doi:

Substances chimiques

Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Filière Santé Maladie Rare
ID : S-PI22005-11C

Auteurs

Christophe Desterke (C)

Faculté de Médecine du Kremlin Bicêtre, Université Paris-Saclay and INSERM UMRS1310, 94270 Le Kremlin-Bicêtre, France.

Raquel Francés (R)

Energy & Memory, Brain Plasticity Unit, CNRS, ESPCI Paris, PSL Research University, 75006 Paris, France.

Claudia Monge (C)

Institut Pasteur, Unité Organisation Nucléaire et Oncogenèse, INSERM U993, 75015 Paris, France.

Agnès Marchio (A)

Institut Pasteur, Unité Organisation Nucléaire et Oncogenèse, INSERM U993, 75015 Paris, France.

Pascal Pineau (P)

Institut Pasteur, Unité Organisation Nucléaire et Oncogenèse, INSERM U993, 75015 Paris, France.

Jorge Mata-Garrido (J)

Institut Pasteur, Unité Organisation Nucléaire et Oncogenèse, INSERM U993, 75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH